$CRBP
Corbus Pharmaceuticals Holdings, Inc.
XNAS•Health Care•Pharmaceutical Preparations
$5.63
▼-2.60%-$0.150
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateCorbus Pharmaceuticals Holdings, Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is CRBP down today? It is at $5.63 (-2.60%), and our scanner flagged it 132 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CRBP spikes, and full due diligence on CRBP — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CRBP 132 times in the last 30 days. Create a free account to track $CRBP, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CRBP from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CRBP today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystClinical / FDA update, from an SEC filing. Read it →Latest filingSC 13GPassive 5%+ stake disclosedSep 30, 2026 · 7 days agoAcross every filing on file, supply equal to 1813.9% of the tradeable float is in play - 1813.9% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
13,563,830 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $127.5M in size · Priced at $9.4/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Ben Yong Director | Sold (automatic/other) | -2K 0.01% of company | sold 18% | 9K | $16K at $7.84 | Sep 14, 26 |
Nicacio Leonardo Viana Officer | Acquired (grant/award) | +58K 0.3% of company | n/a | 58K | n/a | Aug 16, 26 |
Saxena Nishant C Officer | Bought (open market) | +3K 0.01% of company | added 3.5% | 78K | $25K at $9.63 | Aug 11, 26 |
Moran Sean F. Officer | Sold (automatic/other) | -12K 0.06% of company | sold 12% | 85K | $121K at $10.08 | Aug 7, 26 |
Cohen Yuval Officer | Sold (automatic/other) | -17K 0.09% of company | sold 9.8% | 157K | $171K at $10.08 | Aug 7, 26 |
Jenkins John Kenneth Director | Sold (automatic/other) | -5K 0.02% of company | sold 56% | 4K | $38K at $7.91 | Jun 10, 26 |
Altmeyer Anne Director | Sold (automatic/other) | -2K 0.01% of company | sold 24% | 8K | $19K at $7.91 | Jun 10, 26 |
Kung Winston Director | Sold (automatic/other) | -2K 0.01% of company | sold 14% | 12K | $16K at $7.91 | Jun 10, 26 |
Saxena Nishant C Officer | Bought (open market) | +9K 0.05% of company | added 14% | 75K | $68K at $7.58 | Jun 3, 26 |
Saxena Nishant C Officer | Bought (open market) | +5K 0.02% of company | added 7.3% | 66K | $33K at $7.33 | Jun 2, 26 |
Saxena Nishant C Officer | Acquired (grant/award) | +58K 0.3% of company | added 100% | 62K | n/a | May 21, 26 |
Pfeiffenberger Brent Director | Acquired (grant/award) | +8K 0.04% of company | n/a | 8K | n/a | May 19, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on CRBP from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CRBP today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
CRBP last traded at $5.63, down 2.60% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Corbus Pharmaceuticals Holdings, Inc. (CRBP) is next expected to report earnings on Wednesday, November 11, 2026, about 34 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The CRBP Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CRBP 132 times in the last 30 days.
CRBP (Corbus Pharmaceuticals Holdings, Inc.) trades on XNAS, with a market cap of about $106M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CRBP for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CRBP discussion
Sign in to ask a question or join the discussion.